Prestige Consumer Healthcare Inc. $PBH Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC lifted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 292.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 83,439 shares of the company’s stock after buying an additional 62,204 shares during the quarter. SG Americas Securities LLC’s holdings in Prestige Consumer Healthcare were worth $5,207,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. UMB Bank n.a. lifted its holdings in Prestige Consumer Healthcare by 81.8% in the second quarter. UMB Bank n.a. now owns 320 shares of the company’s stock valued at $26,000 after acquiring an additional 144 shares during the period. Bank of Montreal Can increased its holdings in shares of Prestige Consumer Healthcare by 2.0% during the 2nd quarter. Bank of Montreal Can now owns 9,351 shares of the company’s stock valued at $747,000 after purchasing an additional 182 shares in the last quarter. Cerity Partners LLC increased its holdings in shares of Prestige Consumer Healthcare by 5.9% during the 2nd quarter. Cerity Partners LLC now owns 3,884 shares of the company’s stock valued at $310,000 after purchasing an additional 218 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in shares of Prestige Consumer Healthcare by 312.5% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 330 shares of the company’s stock valued at $26,000 after purchasing an additional 250 shares during the period. Finally, F m Investments LLC boosted its holdings in Prestige Consumer Healthcare by 0.5% during the second quarter. F m Investments LLC now owns 53,369 shares of the company’s stock worth $4,262,000 after buying an additional 259 shares in the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, VP Jeffrey Zerillo sold 719 shares of the business’s stock in a transaction that occurred on Friday, November 28th. The stock was sold at an average price of $60.00, for a total transaction of $43,140.00. Following the completion of the sale, the vice president directly owned 42,329 shares in the company, valued at approximately $2,539,740. The trade was a 1.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.40% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on PBH. Canaccord Genuity Group dropped their price target on shares of Prestige Consumer Healthcare from $100.00 to $88.00 and set a “buy” rating on the stock in a research report on Friday, November 7th. Zacks Research upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Weiss Ratings restated a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research note on Wednesday, October 8th. Sidoti raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 price target for the company in a report on Wednesday, September 24th. Finally, Jefferies Financial Group dropped their price objective on Prestige Consumer Healthcare from $75.00 to $71.00 and set a “hold” rating on the stock in a report on Monday, October 27th. Four research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $85.33.

Prestige Consumer Healthcare Stock Up 0.3%

PBH stock opened at $64.16 on Friday. The stock has a market capitalization of $3.08 billion, a P/E ratio of 15.92, a P/E/G ratio of 2.01 and a beta of 0.40. Prestige Consumer Healthcare Inc. has a 52 week low of $57.25 and a 52 week high of $90.04. The firm has a 50-day simple moving average of $60.95 and a 200-day simple moving average of $65.78. The company has a quick ratio of 2.51, a current ratio of 3.70 and a debt-to-equity ratio of 0.55.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, November 6th. The company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.10. Prestige Consumer Healthcare had a return on equity of 12.43% and a net margin of 18.09%.The company had revenue of $274.11 million for the quarter, compared to analysts’ expectations of $257.14 million. During the same period in the previous year, the firm posted $1.09 EPS. Prestige Consumer Healthcare’s revenue was down 3.4% compared to the same quarter last year. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.540-4.580 EPS. Equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare, Inc is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women’s health.

Key brands in Prestige’s portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women’s health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy).